EDIT:NASDAQ
Editas Medicine Inc
၂.၁၇ US$
arrow_upward
+၁.၄၀%(+၀.၀၃၀) 1D
နို ၁၃, GMT-၅ ၁၆:၀၀:၀၁ · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for EDIT...
Open
၂.၁၄ US$
High
၂.၂၁ US$
Low
၂.၀၁ US$
Mkt. cap
၃၃.၄၉ ကုဋေ
Avg. vol.
၂.၄၂ သန်း
Volume
၂.၇၉ သန်း
52-wk high
၃.၉၄ US$
52-wk low
၁.၆၆ US$
EPS
-၀.၆၂ US$
Beta
၂.၀၉
Shares outstanding
၁၅.၄၃ ကုဋေ
No. of employees
၈၇
Open
၂.၁၄ US$
High
၂.၂၁ US$
Low
၂.၀၁ US$
Mkt. cap
၃၃.၄၉ ကုဋေ
Avg. vol.
၂.၄၂ သန်း
Volume
၂.၇၉ သန်း
52-wk high
၃.၉၄ US$
52-wk low
၁.၆၆ US$
EPS
-၀.၆၂ US$
Beta
၂.၀၉
Shares outstanding
၁၅.၄၃ ကုဋေ
No. of employees
၈၇
News stories
From web sources and news partners
Yahoo Finance Singapore
·
ပြီးခဲ့သည့် ၅၆ မိနစ်
Aebi Schmidt Holding (NasdaqGS:AEBI) Stock Fair Value Moves Lower After Soft Q3 And 2026 Cut
Bloomberg
·
ပြီးခဲ့သည့် ၁ နာရီ
Asian Stocks Brace for AI Pressure, Data Dump: Markets Wrap
Stocktwits
·
ပြီးခဲ့သည့် ၂ နာရီ
Dow, S&P 500, Nasdaq Futures Edge Lower As Markets Brace For Nvidia Earnings, Anthropic IPO, Fed Minutes: SMMT, NBIS, HELP, MSTR In Focus
TheStreet
·
ပြီးခဲ့သည့် ၁၅ နာရီ
Goldman Sachs reset S&P 500 price target for 2027
Profile
Editas Medicine, Inc., is a clinical-stage biotechnology company that is developing therapies for rare diseases using CRISPR gene editing technology. Editas Medicine headquarters is located in Cambridge, Massachusetts with additional facilities in Boulder, Colorado. Wikipedia
About Editas Medicine Inc